Premium
Advanced bladder cancer: So many drugs, so little progress
Author(s) -
Dreicer Robert
Publication year - 2008
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.23690
Subject(s) - medicine , bladder cancer , intensive care medicine , disease , accrual , cancer , urothelial cancer , cisplatin , cancer chemotherapy , clinical trial , chemotherapy , surgery , accounting , earnings , business
Accrual to bladder cancer trials in the US has hampered the ability to advance beyond cisplatin‐based chemotherapy for advanced disease. Progress in the management of advanced disease will require new agents and new approaches.